ODAM expression inhibits human breast cancer tumorigenesis

Breast Cancer: Basic and Clinical Research

Volumn 5, Issue 1, 2011, Pages 73-85

  Kestler, Daniel P ^a   Foster, James S ^a   Bruker, Charles T ^b   Prenshaw, John W ^c   Kennel, Stephen J ^a   Wall, Jonathan S ^a   Weiss, Deborah T ^a   Solomon, Alan ^a  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Breast tumor cell inhibition; Cell adhesion; Cell aggregation; Invasion; Tumor imaging

Indexed keywords

ODONTOGENIC AMELOBLAST ASSOCIATED PROTEIN; RECOMBINANT PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL GROWTH; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIPOSOMAL GENE DELIVERY SYSTEM; LUNG LESION; METASTASIS INHIBITION; MOUSE; NONHUMAN; PLASMID; TUMOR VOLUME;

EID: 79958095454     PISSN: 11782234     EISSN: None     Source Type: Journal    
DOI: 10.4137/BCBCR.S6859     Document Type: Article

References (57)

1. Breast cancer facts and fgures; 2009-2010. http://www.cancer.org/ Research/CancerFactsFigures/breast-cancer-facts-fgures-2009-2010.
2. Razzak AR, Lin NU, Winer EP. Heterogeneity of breast cancer and implications of adjuvant chemotherapy. Breast Cancer. 2008;15:31-34.
3. Leber MF, Efferth T. Molecular principles of cancer invasion and metastasis (review). Int J Oncol. 2009;34:881-895.
4. Anderson WF, Matsuno R. Breast cancterogeneity: a mixture of at least two main types? J Natl Cancer Inst. 2006;98:948-951.
5. Kestler DP, Foster JS, Macy SD, Murphy CL, Weiss DT, Solomon A. Expression of odontogenic ameloblast-associated protein (ODAM) in dental and other epithelial neoplasms. Mol Med. 2008;14:318-326.
6. Moffatt P, Smith CE, St-Arnaud R, Nanci A. Characterization of Apin, a secreted protein highly expressed in tooth-associated epithelia. J Cell Bio Chem. 2008;103:941-956.
7. Park JC, Park JT, Son HH, et al. The amyloid protein APin is highly expressed during enamel mineralization and maturation in rat incisors. Eur J Oral Sci. 2007;115:153-160.
8. Siddiqui S, Bruker CT, Kestler D, et al. Odontogenic ameloblast associated protein as a novel biomarker for human breast cancer. Am Surg. 2009;75: 769-775.
9. Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat. 1994;3:325-335.
10. Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol Cell Biol. 2001;21:794-810.
11. Valgeirsdóttir S, Claesson-Welsh L, Bongcam-Rudloff E, Hellman U, Westermark B, Heldin CH. PDGF induces reorganization of vimentin flaments. J Cell Sci. 1998;111:1973-1980.
12. Humphries MJ. Cell substrate adhesion assays. In: Bonifacino JS, Dasso M, Harford JB, Lippincott-Schwartz J, Yamada KM, editors. Current protocols in cell biology. Hoboken, New Jersey: John B. Wiley & Sons; 2007: 9.1.1-9.1.11.
13. Albini A, Benelli R. The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nat Protoc. 2007;2:504-511.
14. Akula MR, Collier TL, Kabalka GW, et al. Microfuidic Synthesis of [18F]FLT. J Nuclear Med. 2010;51(Suppl 2):294P.
15. Solomon A, Murphy CL, Kestler D, et al. Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I. Arthritis Rheum. 2006;54:3545-3550.
16. Ghanem MA, Van der Kwast TH, Sudaryo MK, et al. MIB-1 (KI-67) proliferation index and cyclin-dependent kinase inhibitor p27 (Kip1) protein expression in nephroblastoma. Clin Cancer Res. 2004;10:591-597.
17. Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, Mandal M. ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells. J Cell Physiol. 2010;226:375-384.
18. Pellegrin S, Mellor H. Actin stress fibers. J Cell Sci. 2007;120:3491-3499.
19. Sossey-Alaoui K, Safna A, Li X, et al. Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol. 2007;170:2112-2121.
20. Sugano S, Suzuki Y, Ota T, et al. Hypothetical protein FLJ20513 (FLJ20513 mRNA), Accession AK000520, www.ncbi.nlm.nih.gov/; 2000.
21. www.ncbi.nlm.nih.gov/. UniGene: Hs. 143811 Homo sapiens ODAM expression profile.
22. Solomon A, Murphy CL, Weaver K, et al. Calcifying epithelial odontogenic (Pindborg) tumor-associated amyloid consists of a novel human protein. J Lab Clin Med. 2003;142:348-355.
23. Murphy CL, Kestler DP, Foster JS, et al. Odontogenic ameloblast- associated protein nature of the amyloid found in calcifying epithelial odontogenic tumors and unerupted tooth follicles. Amyloid. 2008;15:89-95.
24. Aung PP, Oue N, Mitani Y, et al. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene. 2006;25:2546-2557.
25. Nishio C, Wazen R, Kuroda S, Moffatt P, Nanci A. Disruption of periodontal integrity induces expression of apin by epithelial cell rests of Malassez. J Periodontal Res. 2011. In press.
26. Martin TA, Watkins G, Mansel RE, Jiang WG. Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer. 2004;40:2717-2725.
27. Liu YN, Lee WW, Wang CY, Chao TH, Chen Y, Chen JH. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene. 2005;24:8277-8290.
28. Bauer H, Zweimueller-Mayer J, Steinbacher P, Lametschwandtner A, Bauer HC. The dual role of zonula occludens (ZO) proteins. J Biomed Biotechnol. 2011. In press.
29. Zou L, Hazan R, Roy P. Proflin-1 overexpression restores adherens junctions in MDA-MB-231 breast cancer cells in R-cadherin-dependent manner. Cell Motil Cytoskeleton. 2009;66:1048-1056.
30. Kominsky SL, Argani P, Korz D, et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 2003;22:2021-2033.
31. Radziwill G, Weiss A, Heinrich J, et al. Regulation of c-Src by binding to the PDZ domain of AF-6. EMBO J. 2007;26:2633-2644.
32. Matter K, Balda MS. Epithelial tight junctions, gene expression and nucleo-junctional interplay. J Cell Sci. 2007;120:1505-1511.
33. Sauermann M, Sahin O, Sültmann H, et al. Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells. Oncogene. 2008;27:1320-1326.
34. McSherry EA, McGee SF, Jirstrom K, et al. JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer. 2009; 125:1343-1351.
35. Naik MU, Naik TU, Suckow AT, Duncan MK, Naik UP. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res. 2008;68:2194-2203.
36. Tam CW, Cheng AW, Ma RY, Yao KM, Shiu SY. Inhibition of prostate cancer cell growth by human secreted PDZ domain-containing protein 2, a potential autocrine prostate tumor suppressor. Endocrinology. 2006;147:5023-5033.
37. Baumgartner M, Radziwill G, Lorger M, Weiss A, Moelling K. c-Src-mediated epithelial cell migration and invasion regulated by PDZ binding site. Mol Cell Biol. 2008;28:642-655.
38. Bambang IF, Xu S, Zhou J, Salto-Tellez M, Sethi SK, Zhang D. Over expression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells. Lab Invest. 2009;89:1229-1242.
39. Bühler H, Schaller G. Transfection of keratin 18 gene in human breast cancer cells causes induction of adhesion proteins and dramatic regression of malignancy in vitro and in vivo. Mol Cancer Res. 2005;3:365-371.
40. Huang H, Sossey-Alaoui K, Beachy SH, Geradts J. The tetraspanin super-family member NET-6 is a new tumor suppressor gene. J Cancer Res Clin Oncol. 2007;133:761-769.
41. Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res. 2009;11:R32.
42. Moffatt P, Smith CE, Sooknanan R, St-Arnaud R, Nanci A. Identification of secreted and membrane proteins in the rat incisor enamel organ using a signal-trap screening approach. Eur J Oral Sci. 2006;114(Suppl 1):139-146.
43. Lee HK, Lee DS, Ryoo HM, et al. The odontogenic ameloblast-associated protein (ODAM) cooperates with RUNX2 and modulates enamel mineralization via regulation of MMP-20. J Cell Biochem. 2010;111:755-767.
44. Pratap J, Imbalzano KM, Underwood JM, et al. Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression. Cancer Res. 2009;69:6807-6814.
45. Barnes GL, Hebert KE, Kamal M, et al. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease. Cancer Res. 2004;64:4506-4513.
46. Javed A, Barnes GL, Pratap J, et al. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci U S A. 2005;102;1454-1459.
47. Pratap J, Wixted JJ, Gaur T, et al. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 2008;68:7795-7802.
48. Coffman JA. Is Runx a linchpin for developmental signaling in metazoans? J Cell Biochem. 2009;107:194-202.
49. Shimoyama A, Wada M, Ikeda F, et al. Ihh/Gli2 signaling promotes osteo-blast differentiation by regulating runx2 expression and function. Mol Biol Cell. 2007;18:2411-2418.
50. Ten-Haaf A, Bektas N, von-Serenyi S, et al. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavorable overall survival. BMC Cancer. 2009;9:298.
51. Xu L, Kwon YJ, Frolova N, et al. Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer. Breast Cancer Res Treat. 2010;123:59-71.
52. Watkins N, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature. 2003;422:313-317.
53. Saqui-Salces M, Merchant JL. Hedgehog signaling and gastrointestinal cancer. Biochim Biophys Acta. 2010;1803:786-95.
54. Li X, Decker M, Westendorf JJ. TEThered to Runx: novel binding partners for runx factors. Blood Cells Mol Dis. 2010;45:82-85.
55. Li X, Hoeppner LH, Jensen ED, Gopalakrishnan R, Westendorf JJ. Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors. J Cell Biochem. 2009;108:378-387.
56. Leong DT, Lim J, Goh X, et al. Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility. Breast Cancer Res. 2010;12:R89.
57. Nishio C, Wazen R, Kuroda S, Moffatt P, Nanci A. Expression pattern of odontogenic ameloblast-associated and amelotin during formation and regeneration of the junctional epithelium. Eur Cell Mater. 2010;20:393-402.